Takeda Pharmaceutical Company Limited (FRA:TKD)
Germany flag Germany · Delayed Price · Currency is EUR
30.62
+0.16 (0.53%)
At close: Mar 13, 2026

FRA:TKD Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
49,08041,70240,22746,82040,20447,993
Market Cap Growth
16.68%3.67%-14.08%16.45%-16.23%10.12%
Enterprise Value
75,19472,21270,36875,24767,12283,681
Last Close Price
30.6226.3524.0026.8521.9324.94
PE Ratio
80.0162.5445.5721.3323.5716.57
PS Ratio
2.021.471.541.681.521.95
PB Ratio
1.180.970.901.060.951.20
P/FCF Ratio
8.947.8812.148.085.426.92
P/OCF Ratio
7.606.399.166.924.836.16
EV/Sales Ratio
3.082.552.692.702.543.40
EV/EBITDA Ratio
10.399.4810.048.467.6511.04
EV/EBIT Ratio
22.8620.7622.9917.5415.0925.62
EV/FCF Ratio
13.7013.6521.2312.999.0612.07
Debt / Equity Ratio
0.710.730.750.770.850.98
Debt / EBITDA Ratio
4.093.964.573.794.075.16
Debt / FCF Ratio
5.375.9410.105.814.815.64
Net Debt / Equity Ratio
0.620.680.690.680.700.79
Net Debt / EBITDA Ratio
3.743.814.383.373.354.17
Net Debt / FCF Ratio
4.725.499.255.173.964.56
Asset Turnover
0.290.310.290.300.270.25
Inventory Turnover
1.161.301.301.361.401.34
Quick Ratio
0.540.440.500.490.731.00
Current Ratio
1.191.011.110.971.211.53
Return on Equity (ROE)
1.50%1.52%2.12%5.27%4.24%7.60%
Return on Assets (ROA)
2.47%2.40%2.15%2.85%2.88%2.06%
Return on Invested Capital (ROIC)
2.76%2.91%4.35%5.15%4.82%4.50%
Return on Capital Employed (ROCE)
4.70%4.80%3.90%5.40%5.40%3.80%
Earnings Yield
1.25%1.60%2.20%4.69%4.24%6.04%
FCF Yield
11.19%12.69%8.24%12.37%18.44%14.44%
Dividend Yield
3.83%4.59%4.80%4.64%6.08%5.56%
Payout Ratio
277.04%280.28%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-0.25%-1.58%-0.67%0.46%-0.23%-0.47%
Total Shareholder Return
3.58%3.01%4.13%5.10%5.85%5.09%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.